Roivant Sciences Ltd. Common Shares (ROIV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Roivant Sciences Ltd. Common Shares (ROIV) is Neutral.

The composite score behind that read is +0.01, weighing +0.14 of bullish evidence against -0.28 bearish.

Roivant Sciences Ltd. Common Shares last closed at $34.59, -2.40% on the session.

Against the IVW growth benchmark the position is -1.97% over the forecast window.

The read is built from 12 underlying insights — 5 bullish and 7 bearish.

Agreement across those insights is 58%.

Roivant Sciences Ltd. Common Shares has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Roivant Sciences Ltd. Common Shares in the 34th percentile on return on equity, where 100 is best.

Roivant Sciences Ltd. Common Shares is classified under Health Care / Biotechnology, with a market capitalisation of $25.60B.

StockMap tracks Roivant Sciences Ltd. Common Shares as the 13th largest of the 386 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 307 Neutral, 66 Moderate Underperform and 13 Moderate Outperform.

On that composite Roivant Sciences Ltd. Common Shares ranks 87th of 386 in the group, against a group median of -0.08.